The current problem with DeFi is that the organic demand for on-chain credit, borrowing to fund productive economic activity, ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Communication is essential to success in both personal and professional life. When boiled down to its bare bones, any interaction between two individuals is entirely about attempting to communicate ...

No matter if you’re day trading penny stocks or you’re looking for stocks under $10 to add to your long-term portfolio, you need to open a brokerage account before you can begin trading. Your broker ...

There’s not much that even the savviest citizens can do to stop what is coming. By default, they must look after themselves and focus on their ability to survive and prosper in various uncomfortable ...

Long-term US fund flows slowed significantly in March, bringing in under $48 billion. This was the lowest monthly intake since April 2025’s net outflow as investors recoiled to the impacts of the war ...

From market cap to ETF weightings, these visuals show how much the Magnificent 7 shape today’s market. Vikki Velasquez is a researcher and writer who has managed, coordinated, and directed various ...

Chart Industries and Flowserve agreed to merge in an all-stock deal worth approximately $19 billion, the companies announced Wednesday. Both stocks were falling after the news. The move brings ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...